Sort
30,917 grants matching “tumor microenvironment”
Targeting TIGIT and PD-1 in Melanoma
$357,994Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Role of ICAM1 in development and progression of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Role of Sirt2 in T Cell Metabolism
$357,994Sungjune Kim · Mayo Clinic Jacksonville · R37 · FY2025 · CA
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$357,994Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$357,994Laurie E Littlepage · University Of Notre Dame · R01 · FY2025 · CA
Extracellular vesicle RNA signaling in liver tumor microenvironment
$357,994Tushar Patel · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Extracellular vesicle RNA signaling in liver tumor microenvironment
$357,994Tushar Patel · Mayo Clinic Jacksonville · R01 · FY2018 · CA
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$357,994Laurie E Littlepage · University Of Notre Dame · R01 · FY2021 · CA
Surgery triggered immune response and liver metastases
$357,951Allan Tsung · Ohio State University · R01 · FY2019 · CA
Computational model of targeted drug delivery
$357,950Dieter Haemmerich · Medical University Of South Carolina · R01 · FY2025 · CA
Specialized Niches for Pediatric Astrocytoma Cells
$357,933Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Bile acids restrict functional reprogramming of myeloid-derived suppressor cells in tumor beds
$357,915Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Characterizing oncogenic function of ITCH in melanoma
$357,913Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Spatial omics technologies to map the senescent cell microenvironment
$357,900Nicola Neretti · Brown University · UG3 · FY2021 · CA
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
$357,895Daniel J Brat · Northwestern University At Chicago · R01 · FY2019 · CA
Pre-Clinical Evaluation Core
$357,891Mandi J. Lopez · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
Targeting Mechanisms of Endocrine Resistance in Breast Cancer
$357,880Myles A Brown · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Altered Proteoglycan Gene Expression and Cancer
$357,873Renato V. Iozzo · Thomas Jefferson University · R01 · FY2019 · CA
Engineering S. typhimurium for metastatic colorectal cancer
$357,852Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · EB
CANCAN - SALK
$357,827Janelle S Ayres · Salk Institute For Biological Studies · OT2 · FY2023 · CA
Targeting TIGIT and PD-1 in Melanoma
$357,804Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Elucidation and therapeutic exploitation of PAK mediated radioresistance
$357,803Sunil J Advani · University Of California, San Diego · R37 · FY2018 · CA
Impact of CREB-driven mechanism in shaping the tumor-immune landscape
$357,796Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R01 · FY2025 · CA
Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM
$357,764Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2018 · CA
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$357,712Yuhang Zhang · University Of Cincinnati · R01 · FY2022 · CA